Exane Derivatives’s Okta OKTA Stock Holding History

Exane Derivatives’s Portfolio OKTA Stock Details OKTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.36K	Sell	15 -720	-98%	-$77.8K	﹤0.01%	473
2022 Q1	$111K	Sell	735 -108	-13%	-$19.4K	0.03%	457
2021 Q4	$189K	Sell	843 -239	-22%	-$56.9K	0.05%	343
2021 Q3	$257K	Sell	1,082 -209	-16%	-$51.9K	0.06%	328
2021 Q2	$322K	Buy	1,291 +36	+3%	+$8.69K	0.07%	269
2021 Q1	$277K	Buy	1,255 +655	+109%	+$165K	0.08%	241
2020 Q4	$153K	Buy	+600	New	+$143K	0.04%	343

Other funds holding OKTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exane Derivatives's OKTA Position: Q2 2022 in Review

Exane Derivatives reduced its Okta (OKTA) stake by 98% in Q2 2022, selling an estimated $77.8K and leaving 15 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #473.

Exane Derivatives first reported a position in OKTA in Q4 2020 and has held it in 7 quarters since. The position peaked at $322K in Q2 2021. 606 funds tracked by Wall St. Rank hold OKTA as of Q2 2022.

Exane Derivatives held 15 shares of Okta worth $1.36K as of Q2 2022.
Exane Derivatives sold 720 Okta shares in Q2 2022, an estimated $77.8K.
Okta made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #473 holding.
Exane Derivatives first reported a position in Okta in Q4 2020 and has held it in 7 quarters since.
Exane Derivatives's Okta position peaked at $322K in Q2 2021.
606 funds tracked by Wall St. Rank held Okta as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.